Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil

Pharmaceutical Development and Technology

Volumn 20, Issue 3, 2015, Pages 266-270

  Alanazi, Fars K ^a   Haq, Nazrul ^a,b   Radwan, Awwad A ^a   Alsarra, Ibrahim A ^a,b   Shakeel, Faiyaz ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Center of Excellence in Biotechnology Research   (Saudi Arabia)

Author keywords

Cholesteryl maleoyl 5 fluorouracil; Droplet size; Drug release; Nanoemulsion; Zeta potential

Indexed keywords

CHOLESTEROL; CHOLESTERYL MALEOYL 5 FLUOROURACIL; FLUOROURACIL; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIMETABOLITE; EMULSION; LIPID; NANOPARTICLE;

ARTICLE; CHOLESTEROL RICH NANOEMULSION; CYTOTOXICITY; DRUG CONJUGATION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; IN VITRO STUDY; NANOEMULSION; NANOPHARMACEUTICS; PARTICLE SIZE; PRIORITY JOURNAL; REFRACTION INDEX; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY; DRUG DELIVERY SYSTEM; EMULSION; MEDICINAL CHEMISTRY; PROCEDURES; TIME; VISCOSITY;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; EMULSIONS; FLUOROURACIL; LIPIDS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; TIME FACTORS; VISCOSITY;

EID: 84920728387     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2013.860551     Document Type: Article

References (30)

1. Rossella P, Massimo B, Simona G, Christopher AJ. Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues. J Pharm Biomed Anal. 2005; 38: 738-745
2. Dong Z, Zheng W, Xu Z, Yin Z. Improved stability and tumor targeting of 5-fluorouracil by conjugation with hyaluronan. J Appl Polym Sci. 2013; 130: 927-932
3. Presant CA, Jacobson J, Wolf W, et al. Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil?. A Southwest oncology group study. Invest New Drugs. 2002; 20: 369-376
4. Longley DB, Harkin DP, Johnston PG. Reviews and comments from the nature publishing group. Nat Rev Cancer. 2003; 3: 330
5. Koukourakis GV, Kouloulias V, Koukourakis MJ, et al. Efficacy of the oral fluorouracil prodrug capecitabine in cancer treatment: a review. Molecules. 2008; 13: 1897-1922
6. Kuzuhara S, Ohkoshi N, Kanemaru K, et al. Subacute leucoencephalopathy induced by carmofur, a 5f-fluorouracil derivative. Neurology. 1987; 234: 365-370
7. Casado E, Pfeiffer P, Feliu J, et al. UFT (tegafur uracil) in rectal cancer. Ann Oncol. 2008; 19: 1371-1378
8. Cosco D, Paolino D, Muzzalupo R, et al. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil. Biomed Microdevices. 2009; 11: 1115-1125
9. Gupta RR, Jain SK, Varshney M. AOT water-in-oil microemulsions as a potential enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf B. 2005; 41: 25-32
10. Li S, Wang A, Jiang W, Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer. 2008; 8: E103
11. Lin Y, Li Y, Ooi CP. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy. J Mater Sci Mater Med. 2012; 23: 2453-2460
12. Ahmad MZ, Akhtar S, Anwar M, Ahmad FJ. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer. Mol Pharm. 2012; 9: 2986-2994
13. Ashwanikumar N, Kumar NA, Nair SA, Kumar GV. Methacrylicbased nanogels for the pH-sensitive delivery of 5-fluorouracil in the colon. Int J Nanomed. 2012; 7: 5769-5779
14. Shishu K, Maheshwari M. Development and evaluation of novel microemulsion based oral formulations of 5-fluorouracil using noneverted rat intestine sac model. Drug Dev Ind Pharm. 2012; 38: 294-300
15. Thomas AM, Kapanen AI, Hare JI, et al. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy. J Controlled Release. 2011; 150: 212-219
16. Yanyu X, Fang L, Qineng P, Hao C. The influence of the structure and the composition of water/AOT-Tween 85/IPM microemulsion system on transdermal delivery of 5-fluorouracil. Drug Dev Ind Pharm. 2012; 38: 1521-1529
17. Yassin AEB, Anwer MK, Mowafy HA, et al. Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci. 2010; 7: 398-408
18. Zhang Z, Wo Y, Zhang Y, et al. In vitro study of ethosome penetration in human skin and hypertrophic scar tissue. Nanomedicine. 2012; 8: 1026-1033
19. Valduga CJ, Fernandes DC, Lo Prete AC, et al. Use of a cholesterolrich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide. J Pharm Pharmacol. 2003; 55: 1615-1622
20. Moura JA, Valduga CJ, Tavares ER, et al. Novel formulation of a methotrexate derivative with a lipid nanoemulsion. Int J Nanomed. 2011; 6: 2285-2265
21. Maranhão RC, César TB, Pedroso-Mariani SR, et al. Metabolic behavior in rats of a non-protein microemulsion resembling low density lipoprotein. Lipids. 1993; 28: 691-696
22. Ades A, Carvalho JP, Graziani SR, et al. Uptake of a cholesterol rich emulsion by neoplastic ovarian tissues. Gynecol Oncol. 2001; 81: 84-87
23. Graziani SR, Igreja FAF, Hegg R, et al. Uptake of a cholesterol-rich emulsion by breast cancer. Gynecol Oncol. 2002; 85: 493-497
24. Azevedo CH, Carvalho JP, Valduga CJ, Maranhão RC. Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma. Gynecol Oncol. 2005; 97: 178-182
25. Rodrigues DG, Maria DA, Fernandes DC, et al. Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies. Cancer Chemother Pharmacol. 2005; 55: 565-576
26. Dias ML, Carvalho JP, Rodrigues DG, et al. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers. Cancer Chemother Pharmacol. 2007; 59: 105-111
27. Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007; 66: 227-243
28. Shakeel F, Haq N, Elbadry M, et al. Ultra fine super selfnanoemulsifying drug delivery system enhanced solubility and dissolution of indomethacin. J Mol Liq. 2013; 180: 89-94
29. Bali V, Ali M, Ali J. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamics, pharmacokinetic and stability assessment. Int J Pharm. 2011; 403: 46-56
30. Villar AM, Naveros BC, Campmany AC, et al. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharm. 2012; 431: 161-175